ReproCELL's night PTS trading price has remained around ¥136, below the previous day's closing price. The latest opening, high and low prices, trading volume and value are also reported. For the fiscal year ending March 2027, first-quarter revenue was ¥500 million and the operating loss was ¥300 million. Ordinary and net losses improved significantly year on year due to subsidy income and foreign exchange gains.
ReproCELL's night PTS price has remained around ¥136. As of 23:24, the trading price was ¥136, the opening price was ¥137.1, the high was ¥137.1, the low was ¥136, trading volume was approximately 300 shares and trading value was approximately ¥41 thousand. The price was down 1.45% from the Tokyo Stock Exchange close, showing the price movement in night trading.
Night PTS refers to night trading through JapanNext Securities' J-Market. It is explained as operating from 17:00 to 6:00 the following morning, as on a regular trading day. The calculation method for the change from the Tokyo Stock Exchange close and the significance of night-trading prices are also explained.
The next earnings announcement date has not been set. In the first quarter of the fiscal year ending March 2027, revenue was ¥500 million, up 14.9% year on year, and the operating loss was ¥300 million. Ordinary and net losses improved significantly year on year due to subsidy income and foreign exchange gains.
Future performance checkpoints include expanding research-support revenue and contract manufacturing, while front-loaded research and development spending and delays in reviews have been identified as risk factors.